Back to Search
LINDSAY HORTON, MD
MD
Neurology Physician
NPI: 1437592011IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
S2343(TX)
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 2013
Research & Publications (20)
The source and secretion of immunoactive relaxin in rat milk.
PMID 19234058·Exp Biol Med (Maywood)·2009
7-preclinical
Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
PMID 18819100·Prostate·2009
7-preclinical
Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I.
PMID 18948404·Endocrinology·2009
4-observational
Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
PMID 18838594·Antimicrob Agents Chemother·2009
8-other
Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.
PMID 18276763·Endocrinology·2008
7-preclinical
A chromosomal inversion within a quantitative trait locus has a major effect on adipogenesis and osteoblastogenesis.
PMID 17584978·Ann N Y Acad Sci·2007
7-preclinical
Genetic dissection of mouse distal chromosome 1 reveals three linked BMD QTLs with sex-dependent regulation of bone phenotypes.
PMID 17451375·J Bone Miner Res·2007
7-preclinical
Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.
PMID 17942909·Cancer Res·2007
7-preclinical
Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
PMID 17908994·Clin Cancer Res·2007
7-preclinical
IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo.
PMID 16482567·Prostate·2006
7-preclinical
The parity-related protection against breast cancer is compromised by cigarette smoke during rat pregnancy: observations on tumorigenesis and immunological defenses of the neonate.
PMID 16474179·Carcinogenesis·2006
7-preclinical
Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition.
PMID 16675518·Endocrinology·2006
7-preclinical
Distal Chr 4 harbors a genetic locus (Gct1) fundamental for spontaneous ovarian granulosa cell tumorigenesis in a mouse model.
PMID 15735010·Cancer Res·2005
7-preclinical
Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
PMID 15542029·Bone·2004
7-preclinical
Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma.
PMID 15256463·Cancer Res·2004
7-preclinical
Are there any ethnic differences in the number of coronary artery bypass and valve heart surgeries among Caucasians, African Americans and Puerto Ricans? The western New York experience.
PMID 18084879·J Med·2004
8-other
Immuno-neutralization of circulating relaxin does not alter the breast cancer-protective action of parity in MNU-treated rats.
PMID 15255292·J Exp Ther Oncol·2004
7-preclinical
High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial.
PMID 15499141·Arch Dis Child Fetal Neonatal Ed·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5959 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 645-8800
Quick Facts
- NPI
- 1437592011
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile